Enliven Therapeutics Inc. (ELVN)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

4,386,568 $17,941,063 0.34%
2.
RA Capital Management

Peter Kolchinsky

3,250,724 $13,295,461 0.26%
3.
Woodline Partners

Michael Rockefeller And Karl Kroeker

866,405 $3,543,596 0.04%
4. 776,785 $3,177,051 +715% 0%
5.
Diametric Capital

Nick Thakore

171,942 $703,243 0.33%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$22.07 622 Large Shareholder 718,749 2023-02-23 Filing
$5.11 23,565 Large Shareholder 2,872,513 2023-02-22 Filing
$5.25 8,194 Large Shareholder 2,848,948 2023-02-21 Filing
$4.00 629,297 Large Shareholder 3,880,021 2023-01-03 Filing
$3.93 19,299 Large Shareholder 3,250,724 2022-12-09 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.67 9,856 Officer 27,610 2023-02-22 Filing
$4.66 32,861 Officer 87,835 2023-02-22 Filing
$3.92 3,596 Officer 37,466 2023-01-30 Filing
$3.91 11,313 Officer 120,696 2023-01-30 Filing
$4.00 1,250,000 Large Shareholder 1,767,774 2023-01-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,017,774 $12,342,696 11.79%
2. 928,706 $3,765,903 0%
3. 631,333 $2,582,152 0.4%
4. 441,213 $1,804,561 0%
5. 200,200 $818,818 0.2%